---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-005034"
form_type: "8-K"
ticker: "SVRA"
cik: "0001160308"
company_name: "Savara Inc"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:47:31.943365+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Savara updates corporate presentation; no material new information disclosed

## Summary
- Corporate presentation updated and posted on IR website on January 13, 2025.
- Presentation titled 'Developing New Therapies for Rare Respiratory Diseases'.
- No specific financial data or material events provided in the filing.
- Presentation furnished as Exhibit 99.1 but contains no new material substantive disclosures.

## SEC filing metadata
- accession: 0001193125-25-005034
- form_type: 8-K
- ticker: SVRA
- cik: 0001160308
- company_name: Savara Inc
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1160308/000119312525005034/0001193125-25-005034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1160308/000119312525005034/d912056d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-005034
- JSON: https://secwatch.observer/filing/0001193125-25-005034.json
- Plain text: https://secwatch.observer/filing/0001193125-25-005034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.